Prevalence of Lymphoma in IBD



Status:Completed
Conditions:Irritable Bowel Syndrome (IBS), Lymphoma, Gastrointestinal
Therapuetic Areas:Gastroenterology, Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:April 2006
End Date:October 2008

Use our guide to learn which trials are right for you!

Prevalence and Risk Factor for Lymphoproliferative Disease in Patients With Inflammatory Bowel Disease

Patients with inflammatory bowel disease (IBD) may be at increased risk of lymphoma. The
majority of lymphomas in patients with IBD occur in areas of active inflammation. The
relationship between IBD and lymphoproliferative disease is however unclear, since both
chronic inflammation as well as medications used to treat IBD (especially immunosuppressives
- Azathioprine or 6-MP - and anti-TNF alpha agents) have been associated with increased risk
of lymphoma. We plan to study the association between IBD and lymphoma in a large, mixed,
community based and referral population from the IBD database at Indiana University.


Inclusion Criteria:

- Inflammatory Bowel disease

- Lymphoma
We found this trial at
1
site
545 Barnhill Dr
Indianapolis, Indiana 46201
(317) 274-8157
Indiana University Medical Center Indiana University Health is Indiana
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials